10-K: Kimberly-Clark 2025 Annual Report: Strategic Shifts & Kenvue Acquisition
Annual Report
Kimberly-Clark's 2025 annual report details a strategic pivot with the Kenvue acquisition and IFP joint venture, alongside a 2.1% net sales decline and a 12.9% drop in operating profit from continuing operations.
Summary
- Net sales declined 2.1% to $16.4 billion in 2025, primarily due to divestitures and unfavorable currency impacts, partially offset by 1.7% organic sales growth.
- Gross profit decreased 5.8% to $5.9 billion, with gross margin at 36.0%, a 140 basis point decrease.
- Operating profit decreased 12.9% to $2.4 billion.
- Income from Continuing Operations decreased 24.8% to $1.6 billion.
- Diluted Earnings per Share from Continuing Operations decreased 24.2% to $4.86.
- Adjusted operating profit was $2.7 billion, in line with the prior year, after excluding transformation charges, Kenvue acquisition costs, PPE business sale gain, and intangible asset impairments.
- The company is acquiring Kenvue, Inc., a global consumer health leader, for stock and cash consideration, expecting to issue approximately 280 million shares and pay approximately $6.7 billion in cash.
- A joint venture with Suzano S.A. was formed for the International Family Care and Professional (IFP) segment, with Kimberly-Clark retaining a 49% equity interest and receiving approximately $1.7 billion.
- The 2024 Transformation Initiative is ongoing, aiming for $3.0 billion in gross productivity savings and $200 million in selling, general and administrative expenses reductions, with total pre-tax costs of $1.5 billion. Cumulative pre-tax charges for this initiative were $808 million through December 31, 2025.
- The company completed the sale of its personal protective equipment (PPE) business in 2024 for $635 million, recognizing a pre-tax gain of $566 million.
- The remaining shares of Thinx Inc. were acquired in 2023 for $95 million.
- The Neve tissue brand and related assets in Brazil were sold in 2023 for $212 million, recognizing a pre-tax gain of $74 million.
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mixed filing. While strategic portfolio shifts and cost-saving initiatives are positive long-term signals, the immediate financial performance shows significant declines in net sales, gross profit, and operating profit from continuing operations, indicating ongoing challenges.
Positives
- Organic sales grew by 1.7% in 2025, driven by volume gains of 2.5%.
- Gross productivity savings from integrated margin management were approximately $460 million in 2025.
- Adjusted operating profit remained stable year-over-year at $2.7 billion.
- Income from discontinued operations (IFP Business) increased 3.6% to $400 million, benefiting from gross productivity savings and reduced depreciation/amortization.
- The Kenvue acquisition is expected to enhance the portfolio and drive value.
- The IFP Transaction generated approximately $1.7 billion in proceeds, expected to fund part of the Kenvue acquisition.
- The 2024 Transformation Initiative aims for $3.0 billion in gross productivity and $200 million in SG&A savings by the end of 2026.
- Favorable cash tax impacts are expected in the near and medium term due to the One Big Beautiful Bill Act (OBBBA).
- Maintains a strong liquidity position with the ability to generate cash from operations and access to debt markets.
Negatives
- Net sales declined 2.1% in 2025, primarily due to divestitures and unfavorable currency impacts.
- Gross profit decreased 5.8% and gross margin declined by 140 basis points to 36.0%.
- Operating profit decreased 12.9% due to transformation charges, Kenvue acquisition costs, and the prior year's PPE sale gain.
- Income from Continuing Operations decreased 24.8%.
- Diluted Earnings per Share from Continuing Operations decreased 24.2%.
- Lower pricing partially offset organic sales growth.
- Unfavorable pricing net of cost inflation, including tariff impacts, and supply chain related investments negatively impacted adjusted gross margin.
- Lower income from equity companies, primarily Kimberly-Clark de Mexico, due to unfavorable currency effects and higher input costs.
- Higher effective tax rate (29.2% vs. 18.3%) primarily due to incremental tax charges related to a valuation allowance on U.S. foreign tax credits from OBBBA.
- Cash provided by operations decreased to $2.8 billion from $3.2 billion, driven by lower operating profit and working capital timing impacts, including $110 million in restructuring and IFP Transaction separation cost payments.
- Increased capital spending to $1.1 billion in 2025 from $721 million in 2024.
- Incurred $32 million in acquisition-related costs for Kenvue in 2025.
- Cumulative pre-tax charges for the 2024 Transformation Initiative were $808 million through December 31, 2025.
- Experienced high input costs, supply chain complexities, reduced consumer demand, and restricted access to raw materials/financial institutions in Russia due to the war in Ukraine.
- Incurred approximately $100 million of incremental tariff-related costs in fiscal 2025, primarily within the North America segment.
Risks
- Significant increases in prices for raw materials (pulp, petroleum-based materials), energy, transportation, or other necessary supplies or services, without corresponding increases in selling prices, could adversely affect financial results.
- Failure of key technology systems, cyberattacks, privacy breaches, or data breaches, including those involving third-party service providers and the rapid evolution of artificial intelligence technologies, could have a material adverse effect.
- Inability to obtain cybersecurity insurance in amounts and on terms viewed as appropriate for operations.
- International operations are subject to foreign market risks, including changes in foreign currency exchange rates, currency restrictions, political, social, and economic instability, and the imposition of increased or new tariffs, sanctions, export controls, quotas, or trade barriers.
- No guarantee that ongoing efforts to reduce costs, including the 2024 Transformation Initiative, will be successful or avoid negative impacts on relationships with employees, suppliers, or customers.
- Operations in Russia and the surrounding region are impacted by the war in Ukraine, leading to high input costs, supply chain complexities, reduced consumer demand, restricted access to raw materials and financial institutions, and potential asset impairment.
- Damage to the reputation of Kimberly-Clark or its brands due to adverse publicity, product safety/quality issues, environmental impacts, social responsibility matters, or security breaches could negatively impact sentiment and financial results.
- Inability to attract and retain key personnel could adversely impact the business, leading to increased costs or erosion of competitiveness.
- Disruption in the supply chain or manufacturing/distribution operations due to natural disasters, power outages, labor strikes or shortages, terrorism, epidemics, pandemics, import restrictions, or geopolitical events.
- Engagement in business development activities, including acquisitions or divestitures, involves numerous risks such as litigation, unexpected costs, integration difficulties, business disruption, personnel turnover, and diversion of management's attention.
- Disruptions in the credit markets or changes to credit ratings may adversely affect access to, and the availability and cost of, financing.
- Climate change and other sustainability matters (transition and physical risks) may adversely affect business and operations, including increased costs, regulatory compliance, and shifts in customer/consumer values.
- Intense competition for sales, changes in consumer purchasing patterns (e.g., shifting to lower-cost or private label products, e-commerce), and the inability to innovate or market products effectively could adversely affect financial results.
- Increasing dependence on key retailers and the emergence of new sales channels may adversely affect the business by increasing bargaining power of customers and potentially leading to reduced profitability or loss of significant customers.
- Government regulations and enforcement, and potential litigation (e.g., marketing, antitrust, anti-bribery, data privacy, product liability, environmental, tax), could have an adverse effect on financial results.
- New or revised tax regulations could reduce after-tax income and have an adverse effect on financial results.
- K-C stockholders and Kenvue stockholders will have reduced ownership in the combined company and less influence over management after the Kenvue acquisition.
- The Kenvue mergers may not be completed, or may be delayed, due to conditions such as regulatory approvals, potentially negatively impacting business, results of operations, financial condition, and stock price.
- Litigation relating to the Kenvue mergers could result in an injunction delaying or preventing the closing and/or substantial costs or otherwise negatively affect business and operations.
- Substantial transaction-related costs will continue to be incurred in connection with the Kenvue mergers, which could increase with delays.
- The combined company may not perform as expected and may fail to realize the projected benefits and cost savings of the Kenvue mergers, including operational and other synergies.
- The market price of common stock will continue to fluctuate after the Kenvue mergers, and holders could lose some or all of their investment value.
- Failure to integrate the businesses and operations of K-C and Kenvue successfully in the expected time frame may adversely affect the future results of the combined company.
- The Kenvue mergers may result in a loss of customers, distributors, service providers, suppliers, vendors, joint venture participants, and other business counterparties.
- The indebtedness of the combined company following consummation of the Kenvue mergers will be substantially greater than K-C's standalone indebtedness, which could adversely affect business flexibility.
- Goodwill and other intangible assets could become impaired, resulting in material non-cash charges to results of operations in the future.
Future Outlook
The company expects net input costs, including tariffs, to be broadly in line with fiscal 2025 in 2026, accounting for currency impacts on non-U.S. operations. Capital spending is projected to be approximately $1.3 billion in 2026, including incremental spending from the 2024 Transformation Initiative. Favorable cash tax impacts are anticipated in the near and medium term due to the One Big Beautiful Bill Act (OBBBA). The 2024 Transformation Initiative is slated for completion by the end of 2026, targeting $3.0 billion in gross productivity and $200 million in SG&A savings. The Kenvue Acquisition and IFP Transaction are both expected to close in the second half and mid-2026, respectively. Defined benefit pension plan contributions are estimated at $15 million in 2026, with annual postretirement benefit payments of approximately $45 million through 2035. The company believes its cash generation and debt capacity are sufficient for future needs.
Management Comments
- We are a global company focused on delivering essential products and solutions that solve unmet consumer needs and provide Better Care for a Better World.
- We are committed to using sustainable practices that are designed to support a healthy planet, build strong communities, and enable our business to thrive for decades to come.
- Our policy is to abide by all applicable laws and regulations, and we have internal programs in place to manage global compliance with these various requirements.
- Our long-term business success is tied to building a purpose-led, performance-driven employee culture where our people feel included, valued, heard, and supported.
- We believe the structure of our compensation packages provides the appropriate incentives to attract, retain and motivate our employees.
- We believe our Powering Care strategy, sharpened growth focus, sustainability initiatives, innovation pipeline and continued investment in e-commerce capabilities underpinned by our commitment to delivering Better Care for a Better World make us well positioned relative to these changing external dynamics.
- We believe that our ability to generate cash from operations and our capacity to issue short-term and long-term debt are adequate to fund working capital, obligations related to our 2024 Transformation Initiative, capital spending, pension contributions, share repurchases, dividends and other needs for the foreseeable future.
- At present we believe that the ultimate outcome of these proceedings, individually and in the aggregate, will not materially harm our financial position, results of operations or cash flows.
Industry Context
StockSavvy.ai notes that Kimberly-Clark's strategic moves, particularly the Kenvue acquisition and IFP joint venture, reflect a broader industry trend of consumer health and hygiene companies optimizing portfolios for higher-growth, higher-margin segments while divesting non-core or lower-performing assets. The focus on the 'Powering Care' strategy with pioneering innovation and margin optimization aligns with industry leaders seeking sustainable growth amidst evolving consumer preferences and intense competition from private labels and e-tailers. The company's challenges with birth rate declines in key markets and increased competitive pressures are common themes across the consumer packaged goods sector, necessitating strong brand building and digital marketing investments.
Comparison to Industry Standards
- The filing does not provide specific comparisons to industry benchmarks or comparable companies' projects and results.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| President, International Family Care and Professional | President of K-C Professional | Ehab Abou-Oaf | 2024 | Strategic realignment |
| President, North America | President and CEO, Nestlé Canada | John Carmichael | September 2025 | New appointment |
| President, International Personal Care | President, K-C Asia Pacific | Katy Chen | October 2024 | Strategic realignment |
| Chief Growth Officer | Chief Marketing, Digital and Information Officer at Bayer AG | Patricia Corsi | 2024 | New appointment |
| Senior Vice President and General Counsel | Vice President, Deputy General Counsel and Corporate Secretary at American Airlines | Grant B. McGee | February 2024 | Rejoined company |
| Chief Strategy, Business Development and Administrative Officer | Chief Business, Strategy and Transformation Officer | Jeffrey Melucci | May 2025 | Strategic realignment |
| Senior Vice President and Chief Human Resources Officer | Senior Vice President and Chief Human Resources Officer at Ball Corporation | Stacey Valy Panayiotou | September 2025 | New appointment |
| Chief Research and Development Officer | Executive Vice President, Chief R&D and Innovation Officer at Campbell Soup Company | Craig Slavtcheff | 2024 | New appointment |
| President and Chief Operating Officer | President, North America | Russell Torres | May 2025 | Promotion |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Policy/Procedure Update | Adopted an Information Security Policy detailing the overall risk-based framework and governance for managing and securing information technology assets and information, aligning with the NIST Cybersecurity Framework. | N/A | Enhances cybersecurity risk management and compliance across the enterprise. |
| Policy/Procedure Update | Adopted a cybersecurity incident response plan designed to provide a framework for coordinated identification and response to security incidents, including materiality assessment and reporting protocols. | N/A | Strengthens preparedness and response capabilities for cybersecurity events, ensuring timely and appropriate action. |
| Committee Oversight | The Board of Directors delegated to the Audit Committee oversight responsibility for the risk management program, including cybersecurity, business continuity, IT operational resilience, and data privacy. | N/A | Formalizes and elevates the oversight of critical enterprise risks, ensuring regular review and strategic guidance from the board level. |
| Policy/Procedure Update | The Severance Pay Plan was amended and restated. | August 25, 2025 | Updates terms and conditions for severance benefits, affecting involuntarily terminated employees and potentially impacting workforce reduction strategies. |
| Policy/Procedure Update | The Supplemental Retirement 401(k) and Profit Sharing Plan was amended and restated. | January 1, 2026 | Modifies retirement benefits for eligible employees, particularly those whose benefits are restricted by IRS code limitations, and introduces a two-year vesting requirement for new hires. |
Legal Proceedings
- Settlement agreement reached in the second quarter of 2025 to resolve a qui tam matter related to the former health care business (Avanos Medical, Inc.), with the payment not materially affecting financial position, results of operations, or cash flows.
- Entered into a Deferred Prosecution Agreement (DPA) with the Department of Justice (DOJ) in the third quarter of 2025, resolving the DOJ's investigation into the former health care business, with monetary payments not expected to materially affect financial position, results of operations, or cash flows.
- Subject to federal, state, and local environmental protection laws and regulations, and named a potentially responsible party at a number of sites where hazardous substances are present; compliance obligations are not expected to have a material adverse effect.
- Brazilian tax authority (RFB) audit for 2008-2013 proposed adjustments related to goodwill amortization, with approximately $45 million in dispute (excluding interest); a first instance judge ruled in the company's favor, but an appeal is pending.
- The U.S. Internal Revenue Service proposed an adjustment for 2017 and 2018 federal income tax returns that would increase the amount of the one-time transition tax on certain undistributed earnings of foreign subsidiaries; the company intends to vigorously defend against the assessment.
- The U.S. Internal Revenue Service proposed an adjustment for 2019 and 2020 federal income tax returns that would increase the amount of U.S. income tax on distributions made by minority-owned foreign affiliates; the company intends to vigorously defend against the proposed adjustment.
- Litigation relating to the Kenvue mergers has been filed, including stockholder class action complaints, which could delay or prevent the mergers, divert management attention, or otherwise adversely affect the business.
Related Party Transactions
- The company will form a joint venture with Suzano S.A. and Suzano International Holding B.V., where Kimberly-Clark will retain a 49% equity interest in the Joint Venture, and Suzano's subsidiary will acquire a 51% interest for approximately $1.7 billion.
- Kimberly-Clark de Mexico, S.A.B. de C.V. and subsidiaries ('KCM') is an equity company in which Kimberly-Clark holds a 47.9% ownership interest as of December 31, 2025.
Stakeholder Impact
- Shareholders: Potential dilution from the issuance of approximately 280 million shares for the Kenvue acquisition, reduced influence over the combined company (current K-C shareholders expected to own approximately 54%), potential market price fluctuations, and impact of increased indebtedness. Continued quarterly dividends have been paid since 1935, with $5.04 per share declared in 2025.
- Employees: Expected workforce reductions in the range of 4% to 5% as part of the 2024 Transformation Initiative. Changes to compensation and benefits plans, including amendments to the Supplemental Retirement 401(k) and Profit Sharing Plan and the Severance Pay Plan. Continued focus on health and safety, employee development, engagement, belonging, and inclusion.
- Customers: Potential impact from changes in consumer demand, intense competitive pressures, consolidation within retailer and distribution channels, and the rapid growth of e-commerce. The company aims to address these through innovation, premiumization, and digital marketing.
- Suppliers: Potential impact from supply chain disruptions, volatility in raw material and energy costs, and the company's supplier finance program.
- Creditors: The combined company's indebtedness following the Kenvue acquisition will be substantially greater, which could affect its business flexibility, borrowing costs, and credit ratings.
Next Steps
- Closing of the Kenvue Acquisition in the second half of 2026, subject to foreign regulatory approvals.
- Closing of the IFP Transaction in mid-2026, following satisfaction of consultation requirements and customary closing conditions.
- Completion of the 2024 Transformation Initiative by the end of 2026.
- Contribution of approximately $15 million to defined benefit pension plans in 2026.
- Anticipated annual payments for other postretirement benefit obligations of approximately $45 million through 2035.
- Kimberly-Clark's 2026 Annual Meeting of Stockholders to be held on May 14, 2026.
- Continued monitoring and evaluation of new legislation and guidance related to the Pillar 2 international tax framework.
Key Dates
| Date | Description |
|---|---|
| July 1, 2018 | Adopted highly inflationary accounting for Argentina operations. |
| October 2021 | Members of the Organization for Economic Co-operation and Development/G20 Inclusive Framework on Base Erosion and Profit Shifting Project (Pillar 2) agreed to a two-pillar solution to reform the international tax framework. |
| January 22, 2021 | Board of Directors authorized the 2021 share repurchase program. |
| March 2022 | Significant adjustments to business in Russia began due to the war in Ukraine. |
| April 1, 2022 | Adopted highly inflationary accounting for Trkiye operations. |
| 2023 | Acquisition of the remaining shares of Thinx Inc. |
| June 1, 2023 | Completion of the sale of the Neve tissue brand and related consumer and professional tissue assets in Brazil. |
| March 27, 2024 | Announcement date of the 2024 Transformation Initiative. |
| April 7, 2024 | Announcement date of the sale of the personal protective equipment (PPE) business. |
| July 1, 2024 | Completion date of the sale transaction of the personal protective equipment (PPE) business. |
| June 30, 2025 | Aggregate market value of common stock held by non-affiliates was approximately $42.8 billion. |
| July 4, 2025 | The One Big Beautiful Bill Act (OBBBA) was enacted in the U.S. |
| August 25, 2025 | Severance Pay Plan amended and restated. |
| September 4, 2025 | Beginning of election period for 2025 Chester Facility Voluntary Incentive Separation Program. |
| September 19, 2025 | End of election period for 2025 Chester Facility Voluntary Incentive Separation Program. |
| October 15, 2025 | Termination Date for 2025 Chester Facility Voluntary Incentive Separation Program. |
| November 2, 2025 | Entry into Agreement and Plan of Merger to acquire Kenvue, Inc. |
| December 31, 2025 | Fiscal year ended for the Annual Report on Form 10-K. |
| December 2025 | Entry into the New Revolving Credit Facility and Delayed Draw Term Loan (DDTL) Credit Facility. |
| January 1, 2026 | Supplemental Retirement 401(k) and Profit Sharing Plan amended and restated effective date. |
| January 29, 2026 | Kimberly-Clark and Kenvue stockholders approved the merger. |
| January 30, 2026 | Number of common stock shares outstanding was 331,922,371. |
| February 4, 2026 | Hart-Scott-Rodino Antitrust Improvements Act waiting period expired for the Kenvue Acquisition. |
| February 12, 2026 | Date of signing for the Annual Report on Form 10-K. |
| May 14, 2026 | Date of Kimberly-Clark's 2026 Annual Meeting of Stockholders. |
| Mid-2026 | Expected closing date for the IFP Transaction. |
| Second half of 2026 | Expected completion date for the Kenvue Acquisition. |
| End of 2026 | Expected completion date for the 2024 Transformation Initiative. |
| November 2, 2026 | Outside date for Kenvue merger completion (subject to automatic extension). |
Recommendation
holdKimberly-Clark is undergoing a significant strategic transformation, including a major acquisition (Kenvue) and a substantial divestiture (IFP Business), which are expected to reshape its portfolio and financial structure. While these moves aim for long-term growth and margin optimization, the immediate financial results for 2025 show declines in key metrics like net sales and operating profit from continuing operations. The increased debt load post-Kenvue acquisition and ongoing transformation costs introduce near-term uncertainties. Seasoned investors would likely hold to observe the successful integration of Kenvue, the realization of anticipated synergies and cost savings from the transformation, and the effective management of the increased debt.
Keywords
Kimberly-Clark, KMB, 10-K, Annual Report, Consumer Goods, Personal Care, Baby & Child Care, Adult Care, Feminine Care, Family Care, Professional Products, Kenvue Acquisition, Joint Venture, Suzano, IFP Transaction, 2024 Transformation Initiative, Financial Results, SEC Filing, Corporate Governance, Risk Management, Sustainability, Supply Chain, Merger, Divestiture, Earnings, Revenue, Profit, Debt, Share Repurchase, Dividends
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.